In other recent news, Medline Inc has been the focus of several financial analysts who have initiated coverage on the company’s stock. BofA Securities, BTIG, and TD Cowen have all given Medline a Buy ...

“Medline’s IPO was the largest private equity-backed IPO of all time, the largest healthcare IPO ever and the largest public offering of 2025, having traded up strongly on debut,” Robert Schmidt, ...

Jan 12 (Reuters) - Brokerages began coverage of Medline (MDLN.O), opens new tab with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's ...

Investing.com -- Wall Street analysts initiated coverage on Medline Industries, pointing to high visibility on revenue growth, a differentiated private-label model and scope for margin expansion after ...

Medline (MDLN) has drawn attention after recent trading left the shares around $40.52, with a 1 day decline and a small year to date negative return. This has prompted fresh interest in its valuation ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...

The First Trust U.S. Equity Opportunities ETF (NYSE: FPX) is solidifying its status as a leader for newly public companies after becoming the first ETF to add Medline Industries (NASDAQ: MDLN) ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline Inc. completed a record-setting $6.26B IPO, allocating proceeds primarily to reduce leveraged buyout debt from 2021. MDLN operates globally with $20.6B YTD revenue, stable 10% growth, and ...

When the Mills family sold Medline Inc. to private equity in one of the largest leveraged buyouts ever, the $32 billion deal seemed the apotheosis of a Covid economy defined by low interest rates and ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares ...

Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...